• 1. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles Benzoxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles

Professional Introduction to Compound with CAS No. 6481-01-2 and Product Name: 2,5,7-trichloro-1,3-benzoxazole

2,5,7-trichloro-1,3-benzoxazole (CAS No. 6481-01-2) is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic aromatic structure, characterized by its three chlorine substituents at the 2, 5, and 7 positions on the benzoxazole ring, has garnered considerable attention due to its versatile reactivity and potential applications in drug development. The presence of chlorine atoms not only enhances its electronic properties but also influences its interaction with biological targets, making it a valuable scaffold for medicinal chemists.

The benzoxazole core is a well-known pharmacophore found in numerous bioactive molecules. Its fused oxygen and nitrogen heterocycles contribute to favorable interactions with biological systems, often serving as key structural elements in antimicrobial, antiviral, and anticancer agents. The introduction of chlorine atoms into the benzoxazole framework modifies its electronic distribution and lipophilicity, which can be strategically exploited to optimize pharmacokinetic profiles and binding affinity.

Recent advancements in computational chemistry have enabled more precise predictions of the behavior of 2,5,7-trichloro-1,3-benzoxazole in complex molecular environments. Studies utilizing molecular modeling techniques have revealed that the chlorine substituents enhance the compound's ability to engage with hydrophobic pockets in protein targets. This insight has guided the design of derivatives with improved solubility and metabolic stability, critical factors for successful drug candidates.

In the realm of medicinal chemistry, 2,5,7-trichloro-1,3-benzoxazole has been explored as a precursor for synthesizing novel therapeutic agents. Its reactive chlorine atoms make it susceptible to nucleophilic substitution reactions, allowing for the introduction of diverse functional groups. Researchers have leveraged this property to develop libraries of analogs targeting specific disease pathways. For instance, modifications at the 2-position have been shown to modulate the compound's interaction with enzymes involved in inflammatory responses.

One particularly intriguing application lies in its potential use as an intermediate in the synthesis of kinase inhibitors. Kinases are pivotal enzymes in cellular signaling networks, and their dysregulation is implicated in various cancers and inflammatory diseases. The electron-withdrawing nature of the chlorine atoms in 2,5,7-trichloro-1,3-benzoxazole facilitates its incorporation into molecules designed to disrupt kinase activity. Preliminary studies have demonstrated promising results in inhibiting aberrant signaling cascades associated with these disorders.

The synthesis of 2,5,7-trichloro-1,3-benzoxazole itself is a testament to the ingenuity of organic chemists. Traditional methods involve chlorination reactions on pre-formed benzoxazole derivatives or multi-step sequences involving cyclization and halogenation. Modern synthetic approaches have focused on optimizing yields and minimizing byproducts through catalytic methods or flow chemistry techniques. These innovations not only improve efficiency but also align with green chemistry principles by reducing waste and energy consumption.

The compound's stability under various conditions is another area of active investigation. Thermal analysis has revealed that 2,5,7-trichloro-1,3-benzoxazole exhibits decent stability at moderate temperatures but degrades under extreme heat or prolonged exposure to light. This knowledge is crucial for formulating stable pharmaceutical products and ensuring their efficacy during storage and transport. Additionally, spectroscopic studies have provided insights into its electronic transitions and hydrogen bonding capabilities, which are relevant for understanding its behavior in solution-phase reactions.

Recent patents highlight the commercial interest in 2,5,7-trichloro-1,3-benzoxazole as a building block for proprietary drug candidates. These filings describe novel synthetic routes that enhance scalability while maintaining high purity standards essential for pharmaceutical use. The growing body of literature underscores its significance as a versatile intermediate capable of generating structurally diverse molecules with tailored biological activities.

The environmental impact of working with benzoxazole derivatives has also prompted research into sustainable practices. Biocatalytic methods have been explored as alternatives to traditional chemical transformations to reduce reliance on hazardous reagents. Such efforts not only mitigate environmental risks but also align with regulatory pressures favoring greener methodologies across industries.

In conclusion,2,5,7-trichloro-1,3-benzoxazole (CAS No. 6481-01-2) represents a compelling example of how structural modifications can unlock new opportunities in drug discovery and material science. Its unique combination of reactivity and stability makes it an indispensable tool for synthetic chemists aiming to develop next-generation therapeutics targeting complex diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)